Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Ishares Msci Brazil ETF (EWZ) vs Eli Lilly And Co (LLY) Price & Performance

Ishares Msci Brazil ETFTrade
Eli Lilly And CoTrade

Price performance (Past 24H)

Key statistics

Ishares Msci Brazil ETF vs Eli Lilly And Co — how do they compare? Ishares Msci Brazil ETF trades at $33.92, while Eli Lilly And Co trades at $1,225.66 (market cap $1.08T). The key difference: Eli Lilly And Co pays a 0.57% dividend while Ishares Msci Brazil ETF pays none. Which is the better fit depends on your goals.

EWZLLY
Sector
Broad Market / FactorHealth
52-Week High
$41.75$1.24K
52-Week Low
$27.36$639.43
Market Cap
$1.08T
Enterprise Value
$1.13T
Dividend Yield
0.57%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Ishares Msci Brazil ETF

EWZ, the iShares MSCI Brazil ETF, trades at $33.94, down 3.55% today, with a bearish technical signal driven by moving averages. The ETF faces headwinds from US tariffs on Brazilian goods and mixed sentiment, though oscillators suggest potential near-term support. A dividend of $0.33 is scheduled for June 2026, while institutional investors like Empowered Funds LLC have recently increased positions, indicating some confidence in Brazilian equity value.

The outlook for EWZ hinges on Brazil's economic policies and commodity markets, offering exposure to emerging market growth but with volatility risks from trade tensions and currency fluctuations. Investors should weigh the ETF's high expense ratio against alternatives like FLBR, which offers lower costs and higher dividends, as noted in recent analyst comparisons.

Eli Lilly And Co

Eli Lilly (LLY) trades at $1,231.58, up 3.87% in the past 24 hours, reflecting strong momentum near its 52-week high. The stock exhibits bullish technical signals with robust fundamentals, including 48% revenue growth in Q2 2026 and a net income margin of 33.53%. Recent news highlights legal actions against black-market drug sales and positive analyst sentiment following earnings beats.

Outlook remains positive with a consensus price target of $1,380, though high valuation ratios (P/E 40.79) and regulatory risks pose challenges. Earnings growth and pipeline advancements, like retatrutide, drive upside potential, but investors should monitor competitive pressures and execution risks.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Ishares Msci Brazil ETF

EWZ is a country-specific ETF that tracks the Brazilian equity market. It provides exposure to large and mid-sized companies in Brazil, with a heavy focus on financials and materials, including major names like Nu Holdings, Vale, and Itaú Unibanco.

Read more on EWZ

About Eli Lilly And Co

Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer

Read more on LLY